The present invention relates to a novel method for preparing lithium bis(fluorosulfonyl)imide and, more specifically, to a method for preparing lithium bis(fluorosulfonyl)imide, capable of simply and economically preparing lithium bis(fluorosulfonyl)imide, which is a lithium salt to be used in an electrolyte solution for a lithium secondary battery, in a high yield and with high purity. According to the present invention, the novel method for preparing lithium bis(fluorosulfonyl)imide can resolve the problem of a conventional technique by reacting a bis(chlorosulfonyl)imide compound, which is a starting material, with a fluorination reagent, and then immediately treating the same with an alkali reagent without purification or concentration, and has an effect of enabling lithium bis(fluorosulfonyl)imide to be simply and economically prepared in a high yield and with high purity.

The present invention relates to a novel method for preparing lithium bis(fluorosulfonyl)imide and, more specifically, to a method for preparing lithium bis(fluorosulfonyl)imide, capable of simply and economically preparing lithium bis(fluorosulfonyl)imide, which is a lithium salt to be used in an electrolyte solution for a lithium secondary battery, in a high yield and with high purity. According to the present invention, the novel method for preparing lithium bis(fluorosulfonyl)imide can resolve the problem of a conventional technique by reacting a bis(chlorosulfonyl)imide compound, which is a starting material, with a fluorination reagent, and then immediately treating the same with an alkali reagent without purification or concentration, and has an effect of enabling lithium bis(fluorosulfonyl)imide to be simply and economically prepared in a high yield and with high purity.

A light emitting device including a first electrode, a hole transport region on the first electrode, an emission layer on the hole transport region, an electron transport region on the emission layer, and a second electrode on the electron transport region is provided. The electron transport region includes a polycyclic compound represented by Formula 1:

##STR00001##

A light emitting device including a first electrode, a hole transport region on the first electrode, an emission layer on the hole transport region, an electron transport region on the emission layer, and a second electrode on the electron transport region is provided. The electron transport region includes a polycyclic compound represented by Formula 1:

##STR00001##

A cocrystal having the formula LiX.Math.aM, or a solvate or hydrate thereof, wherein X is a conjugate base of an organic acid, M is a neutral organic molecule, and a is from 0.5 to 4, pharmaceutical compositions comprising such cocrystals, cocrystal solvates, or cocrystal hydrates, and methods of preparing such cocrystals, cocrystal solvates, or cocrystal hydrates, and such pharmaceutical compositions.

A cocrystal having the formula LiX.Math.aM, or a solvate or hydrate thereof, wherein X is a conjugate base of an organic acid, M is a neutral organic molecule, and a is from 0.5 to 4, pharmaceutical compositions comprising such cocrystals, cocrystal solvates, or cocrystal hydrates, and methods of preparing such cocrystals, cocrystal solvates, or cocrystal hydrates, and such pharmaceutical compositions.

A process for a continuous production of a boronic acid derivative based on a Matteson boronic ester homologation and an apparatus of performing the process are disclosed.

A cocrystal having the formula LiX.aM, or a solvate or hydrate thereof, wherein X is a conjugate base of an organic acid, M is a neutral organic molecule, and a is from 0.5 to 4, pharmaceutical compositions comprising such cocrystals, cocrystal solvates, or cocrystal hydrates, and methods of preparing such cocrystals, cocrystal solvates, or cocrystal hydrates, and such pharmaceutical compositions.

A cocrystal having the formula LiX.aM, or a solvate or hydrate thereof, wherein X is a conjugate base of an organic acid, M is a neutral organic molecule, and a is from 0.5 to 4, pharmaceutical compositions comprising such cocrystals, cocrystal solvates, or cocrystal hydrates, and methods of preparing such cocrystals, cocrystal solvates, or cocrystal hydrates, and such pharmaceutical compositions.

The present invention discloses a phenanthroline-based compound and an organic EL device employing the compound as phosphorescent light emitting host material of a light emitting layer and/or electron transporting layer material and/or hole blocking layer material and/or a thermally activated delayed fluorescence (TADF) material of a light emitting layer which can display good performance.